Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil while breastfeeding. We will also discuss about common side effects and warnings associated with Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil.

What is Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil used for?


Shake well before use. Apply liberaly 15 minutes before sun exposure. Children under 6 months old: Ask a doctor. Re-apply every 2 hours. Use water-resistant sunscreen if swimming or sweating. Store in cool dry place.

Brief: A tanning and body oil. Provides SPF 6 protection.

Is using Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil safe or dangerous while breastfeeding?

Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil high risk while breastfeeding
Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil consists two active ingredients Octocrylene and Octinoxate and as per our analysis of both we have determined the Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil in breastfeeding.

Octocrylene and Breastfeeding

Safe

Based on the current available safety data, octocrylene used as a UV filter in cosmetic products at a concentration of 10% can be considered as safe. There was no evidence of any endocrine disruption potential from experimental studies which demonstrated no adverse effects on reproductive (e.g. oestrus cycle, epididymal and testicular sperm parameters) and developmental parameters. Effects on thyroid reported in repeated toxicity studies conducted in rats at very high doses are species?specific and not relevant considering the doses at which octocrylene is used in human.

Four studies on the transdermal absorption of octocrylene are available in the scientific literature, and an additional study is available in ECHA summaries of safety data. Dermal absorption studies of octocrylene showed that most octocrylene concentrations are found in the stratum corneum and that very few quantities are found in the epidermis (0.4%) and in the receptor fluid (<0.05%). In vivo, a very recent study in human volunteers showed systemic exposure to octocrylene with maximal concentrations ranging from 2.9 to 7.8 ng/mL under indoor maximal use conditions. Octocrylene has been found at very low amounts in human milk, and some metabolites of octocrylene were primarily detected in urine of volunteers using sunscreen products.

No systemic effects were reported after dermal exposure to octocrylene in rabbits at very high dose (534 mg/kg bw/day) compared with those used in cosmetic products. After oral exposure, effects on liver and thyroid were reported in a study conducted in rats at high doses (340 and 1085 mg/kg bw/day in males). These effects were investigated in an additional mechanistic study which showed that effects on thyroid were indirect and due to hepatic enzyme induction potential of octocrylene in rats at very high oral doses.

Based on available animal data, octocrylene does not induce developmental or teratogenic effects. In an extended one?generation reproductive toxicity study, only rats treated with the highest dose of octocrylene via oral route showed a decrease in the number of implantation sites and consequently a low number of pups. This very high dose of 550 mg/kg bw/day cannot be considered to be relevant to the dermal use of octocrylene as a cosmetic ingredient. Moreover, no other effects on male and female fertility and reproductive parameters such as oestrus cycle, epididymal and testicular sperm parameters were observed in all groups tested. Regarding pups, no effects on sexual and neurodevelopmental parameters were observed.

Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Octocrylene passing orally in Infants. In some rare cases it can cause skin allergy.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (5001000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.


What should I do if already breastfed my kid after using Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil usage and time interval of breastfeeding.


My doctor has prescribed me Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil then there must be good reason for that as Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Bali Body Spf Cacao Tanning Oil | Octinoxate, Octocrylene Cream Oil in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week